Viking Fund Management LLC Abb Vie Inc. Transaction History

Viking Fund Management LLC

$605 Million
Q3 2024

A detailed history of Viking Fund Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Viking Fund Management LLC holds 126,000 shares of ABBV stock, worth $22.1 Million. This represents 4.11% of its overall portfolio holdings.

Number of Shares

126,000

Previous 142,500 11.58%

Holding current value

$22.1 Million

Previous $24.4 Million 1.8%

% of portfolio

4.11%

Previous 4.42%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$163.84 - $199.33 $2.7 Million - $3.29 Million	-16,500 Reduced 11.58%	126,000 $24.9 Million
Q2 2024 Jul 16, 2024	BUY	$154.79 - $180.76 $1.43 Million - $1.67 Million	9,250 Added 6.94%	142,500 $24.4 Million
Q1 2024 Apr 15, 2024	SELL	$159.82 - $182.1 $1.44 Million - $1.64 Million	-9,000 Reduced 6.33%	133,250 $24.3 Million
Q3 2023 Oct 16, 2023	BUY	$133.59 - $154.65 $1.08 Million - $1.25 Million	8,060 Added 6.01%	142,250 $21.2 Million
Q2 2023 Jul 20, 2023	BUY	$132.51 - $164.9 $820,236 - $1.02 Million	6,190 Added 4.84%	134,190 $18.1 Million
Q1 2023 Apr 17, 2023	BUY	$144.61 - $166.54 $578,440 - $666,160	4,000 Added 3.23%	128,000 $20.4 Million
Q4 2022 Feb 02, 2023	BUY	$138.31 - $165.87 $414,930 - $497,610	3,000 Added 2.48%	124,000 $20.1 Million
Q3 2022 Oct 12, 2022	BUY	$134.21 - $153.93 $1.48 Million - $1.69 Million	11,000 Added 10.0%	121,000 $16.2 Million
Q2 2022 Jul 18, 2022	BUY	$137.62 - $174.96 $550,480 - $699,840	4,000 Added 3.77%	110,000 $16.8 Million
Q4 2021 Jan 14, 2022	BUY	$107.43 - $135.93 $214,860 - $271,860	2,000 Added 1.92%	106,000 $14.4 Million
Q3 2021 Oct 18, 2021	BUY	$106.4 - $120.78 $1.28 Million - $1.45 Million	12,000 Added 13.04%	104,000 $11.2 Million
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $210,420 - $234,420	2,000 Added 2.22%	92,000 $10.4 Million
Q1 2021 Apr 26, 2021	BUY	$102.3 - $112.62 $306,900 - $337,860	3,000 Added 3.45%	90,000 $9.74 Million
Q4 2020 Jan 21, 2021	BUY	$80.49 - $108.67 $965,879 - $1.3 Million	12,000 Added 16.0%	87,000 $9.32 Million
Q2 2020 Jul 27, 2020	BUY	$73.37 - $98.18 $366,850 - $490,900	5,000 Added 7.14%	75,000 $7.36 Million
Q1 2020 Apr 13, 2020	BUY	$64.5 - $97.79 $774,000 - $1.17 Million	12,000 Added 20.69%	70,000 $5.33 Million
Q4 2019 Jan 15, 2020	BUY	$72.13 - $90.25 $721,300 - $902,500	10,000 Added 20.83%	58,000 $5.14 Million
Q3 2019 Oct 10, 2019	BUY	$62.98 - $75.72 $629,800 - $757,200	10,000 Added 26.32%	48,000 $3.64 Million
Q2 2019 Jul 16, 2019	BUY	$65.7 - $83.98 $1.71 Million - $2.18 Million	26,000 Added 216.67%	38,000 $2.76 Million
Q1 2019 Apr 15, 2019	BUY	$77.14 - $90.79 $154,280 - $181,580	2,000 Added 20.0%	12,000 $967,000
Q4 2018 Jan 23, 2019	BUY	$77.85 - $96.01 $778,500 - $960,100	10,000 New	10,000 $922,000

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Viking Fund Management LLC with notifications on news.

Account

Viking Fund Management LLC Abb Vie Inc. Transaction History